Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression (vol 115, 108869, 2019)
第一作者机构：[1]Shanghai Univ TCM, Longhua Hosp, Dept Breast, 725 Wanping South Rd, Shanghai 200032, Peoples R China
推荐引用方式(GB/T 7714)：
Wu Jingjing,Chen Hao,Ye Meina,et al.Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression (vol 115, 108869, 2019)[J].BIOMEDICINE & PHARMACOTHERAPY.2020,122:doi:10.1016/j.biopha.2019.109789.
APA：
Wu, Jingjing,Chen, Hao,Ye, Meina,Wang, Bing,Zhang, Yuzhu...&Chen, Hongfeng.(2020).Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression (vol 115, 108869, 2019).BIOMEDICINE & PHARMACOTHERAPY,122,
MLA：
Wu, Jingjing,et al."Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression (vol 115, 108869, 2019)".BIOMEDICINE & PHARMACOTHERAPY 122.(2020)
